Simplex Trading, LLC Ngm Biopharmaceuticals Inc Transaction History

Simplex Trading, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 25, 2024	SELL	$1.17 - $1.92 $139 - $228	-119 Reduced 80.95%	28 $0
Q4 2023 Feb 02, 2024	SELL	$0.6 - $1.31 $124 - $272	-208 Reduced 58.59%	147 $0
Q3 2023 Nov 01, 2023	BUY	$1.05 - $3.37 $229 - $738	219 Added 161.03%	355 $0
Q2 2023 Aug 04, 2023	BUY	$2.44 - $4.53 $331 - $616	136 New	136 $0
Q3 2021 Oct 28, 2021	SELL	$20.15 - $26.19 $80 - $104	-4 Closed	0 $0
Q2 2021 Aug 12, 2021	SELL	$15.06 - $30.03 $126,052 - $251,351	-8,370 Reduced 99.95%	4 $0
Q1 2021 Apr 26, 2021	BUY	$24.99 - $31.93 $209,266 - $267,381	8,374 New	8,374 $243,000
Q4 2020 Feb 02, 2021	SELL	$16.21 - $31.44 $35,905 - $69,639	-2,215 Closed	0 $0
Q3 2020 Oct 14, 2020	SELL	$15.59 - $19.97 $4,973 - $6,370	-319 Reduced 12.59%	2,215 $35,000
Q2 2020 Jul 13, 2020	BUY	$11.97 - $23.47 $30,331 - $59,472	2,534 New	2,534 $50,000

2.6M

300

Ticker NGM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,365,904
Description
NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer. The company's product candidates include Aldafermin, an engineered analog of human hormone fibroblast growth factor 19, which is in Phase IIb clinical trial...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.